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Abstract
The impact of nutrition on HIV-infected children has been evaluated in 
multiple studies. Our review of the current trends of nutrition-related studies 
revealed that the focus has moved from simply the disease consequences of HIV to 
ensuring that antiretroviral therapy-treated children are well nourished to ensure 
growth and development. This update aims to present the state of the art regard-
ing nutrition of HIV-infected children and the real potential for nutrition to serve 
as a dynamic therapy in this group. Recent World Health Organization reports 
indicate that the HIV/AIDS disease is curbing in incidence worldwide despite the 
high 1.8 million children, less than 15 years, reported in 2017. In addition, the 
literature supports the complexity and bidirectional relation between nutrition 
and HIV. HIV infection has a substantial effect on the nutritional status, in par-
ticular, the gastrointestinal side effects, which, in turn, have a profound impact on 
HIV infection. Advances in the field have transformed the course of the disease 
into a chronic illness, where more attention was given to lifestyle and quality of life 
including nutrition. However, achievement of food security, nutrition accessibility, 
and appropriate handling of nutrition-related complications of HIV infection are 
remarkable challenges, particularly, in resource poor environments, where most 
HIV infections exist.
Keywords: HIV/AIDS, HIV-infected children, nutrition in HIV, nutrition for children, 
adjunct therapy for HIV
1. Introduction
Good nutrition is essential for normal growth and development of children, 
and it is a vital component associated with overall health. Children infected with 
HIV have known increased nutrient needs to maintain optimal nutrition status. 
In addition, the focus of nutrition interventions has moved over the past two 
decades, from simply supporting the patient to ensuring that the treated children 
are well nourished, since they have the additional nutritional demands of growth 
and development [1]. Related studies have also shown that nutrition is not only an 
adjunct therapy but potentially a primary therapy in locations with limited access to 
antivirals [2].
It is also well established that HIV infection has a substantial impact on nutri-
tional status and that nutritional status has a profound effect on the course of HIV 
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infection [3]. The gastrointestinal side effects of HIV treatments have been well 
described in the literature [4].
Advances in screening and treatment modalities have decreased incidence and 
have transformed the course of this disease into a chronic illness [4]. In this respect, 
more attention has been given to the quality-of-life issues such as nutrition [3]. It is 
important to note that the nutrition-related complications of HIV infections, espe-
cially the achievement of food and nutrition security, are remarkable challenges, 
particularly, in countries of poor resources, where most HIV-infections exist. In 
addition, children on highly active antiretroviral therapy (HAART) require higher 
levels of nutritional supplementation, in particular during the initiation period of 
the treatment [5]. To deal with such issues, a series of guidelines have been devel-
oped by WHO and professional societies. However, the adherence to such guide-
lines has been reported to have encountered many obstacles in different countries.
2. Epidemiology of HIV/AIDS in children
Despite the fact that the HIV/AIDS pandemic is curbing, in 2017, there were 
36.9 million people living with HIV (35.1 million adults and 1.8 million children 
<15 years). Only 52% of children living with HIV were receiving lifelong antiretro-
viral therapy (ART). In addition, 940,000 people died from AIDS-related illnesses 
in 2017, while AIDS-related deaths have been reduced by more than 51% since the 
peak in 2004 [6].
It is well established that without treatment, HIV infection causes progressive 
immunosuppression, due to HIV virus-mediated depletion of CD4+ lymphocytes, 
leaving patients at risk of developing opportunistic infections and other HIV-
related disorders [7, 8]. Since the mid-1990s, the introduction of highly active 
antiretroviral therapy (HAART) has remarkably influenced the epidemiology of 
pediatric HIV type 1 infection [9]. Consequently, the prognosis of HIV-infected 
children has markedly improved, both in terms of mortality and morbidity [9, 10].
The mother-to-child transmission (MTCT) was basically the focus for develop-
ing new and innovative strategies to prevent vertical transmission. In the absence of 
preventive measures, the risk of transmission is pretty significant as it ranges between 
15 and 40%. Multiple factors affect the rate of MCTC transmission; they include 
maternal viral load and duration of exposure. The viral transfer is also enhanced 
in the presence of breast lesions or vaginal delivery. In western countries (USA and 
Europe), the MTCT has dropped to less than 1% in the last 10 years [8]. Such a decline 
is basically due to the implementation of new HIV management guidelines, which 
include (a) antenatal testing, (b) antiviral prophylaxis early in pregnancy, (c) elective 
cesarean delivery before labor, and (d) avoidance of breast feeding [8, 11].
Two developments have had the greatest impact on the outcome of pediatric 
HIV infection:
• The availability and use of highly effective, combination antiretroviral therapy 
(ART) and
• The early initiation of ART in HIV-infected infants [11]. Although the mortality 
rate in HIV-infected children is still considerably higher than the pediatric general 
population, it has decreased to 0.5–0.9 per 100 children per year in recent years [9].
Mortality rates in resource-limited environments were 4.5, 6.9, and 7.7% at 1, 2, 
and 3 years, respectively. These rates are similar to those observed among children in 
developed settings [12]. Despite these encouraging results and increasing access to 
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ART, mortality remains high for HIV-infected children in low- and middle-income 
countries. Risk factors for mortality in the first year of ART treatment include young 
age, low CD4 percent, advanced clinical disease, anemia, and low weight for age 
[13, 14]. In resource-limited countries, HIV can infect the most productive family 
members, especially parents, reducing agricultural production and the economic 
capacity of the household, causing insecure provision of food for children [2].
3. HIV infection and malnutrition in children
The cooccurrence of HIV and malnutrition together increases comorbidi-
ties and mortality in affected individuals [15]. Severe acute malnutrition (SAM) 
is of particular concern in children with HIV [1]. SAM is defined by the World 
Health Organization (WHO) as a weight-for-height z-score of less than −3, or 
a mid-upper arm circumference (MUAC) of less than 11.5 cm in children aged 
6 months to 5 years. It can present as either marasmus (protein energy malnutrition 
nonedematous), kwashiorkor (edematous disease), or as marasmic-kwashiorkor. 
However, marasmus is seen more commonly in HIV-positive children. Although the 
prevalence of children with HIV and severe acute malnutrition (SAM) is variable, 
mortality from SAM is more than three times higher in HIV-positive children than 
HIV-negative children. In addition, they have a higher risk of infectious comorbidi-
ties and complications [15–17]. Nine out of 10 studies on HIV-infected children, 
conducted in countries with limited food resources, described low height for age, 
and all 10 studies reported poor weight gain. Such malnutrition was described 
under several forms:
• Chronic malnutrition: In this category, there is small height for age caused by 
several in utero infections. Such infections, which can also occur in early childhood, 
could be coupled with other deficiencies. Such malnutrition has a significant impact 
on the normal development of 39% or 56 million children less than 5 years [18].
• Acute malnutrition: In this form, there is low weight for height resulting from a 
recent infection or a deficiency, whereby vital functions are impaired, leading 
to more mortality. However, the situation could be reversed with the appropri-
ate nutritional support. It affects 9% or 13 million children less than 5 years in 
sub-Saharan Africa [18].
• Underweight: In this group, there is also low weight for age. The child is thin, 
and it is hard to differentiate it from the two other groups. However, it could 
be considered as an indicator to follow up on the nutritional status of a child. 
It has been reported to impact 21% of children below 5 years of age in sub-
Saharan Africa (30 million children). In brief, wide regional disparities have 
been reported in the prevalence of malnutrition in individuals infected with 
HIV. West and Central Africa are among the most impacted by underweight 
and acute malnutrition (22 and 11%, respectively), while the highest chronic 
malnutrition rates are found in East Africa 42% [18].
4. Malnutrition and the immune system
The relationship between malnutrition and HIV in children is complex. These 
two conditions interact and can create a vicious circle of poor health outcomes. 
Moreover, multiple studies have documented the positive effect of appropriate 
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nutrition of vitamins and antioxidants, cofactors of metabolic pathways, in enhanc-
ing and potentiating the immune system. On the other hand, malnutrition has also 
been implicated in impairing immunity, which could even lead to an immunode-
ficiency status with degraded lymphoid tissue containing lower concentrations of 
CD4 cells, target of HIV [5, 15]. In such a weak or deficient immune system, the 
ability to combat infections is reduced. Consequently, malnutrition can speed up the 
progression of the HIV/AIDS disease by creating a favorable environment, which 
contributes to the oxidative stress, which accelerates the death of the immune cells 
and increase viral replication. Stressing the necessity of vitamin A and iron, some 
authors associated their deficiencies with higher mortality risk among HIV/AIDS 
HIV-infected (n =  16) HIV-negative (n =  46) p-Value
Mean ± SEM
Fatty acid metabolites
• NEFA (mmol/L) 0.65 ± 0.10 0.54 ± 0.06 0.285
• Total ketones (μmol/L) 826 ± 259 424 ± 95 0.0387
Acylcarnitines
• C2 (μmol/L) 22.3 ± 3.5 14.4 ± 2.4 0.0103




• Insulin (μIU/ml) 1.81 ± 0.48 2.45 ± 0.45 0.321
• Growth hormone (ng/ml) 12.4 ± 2.7 11.0 ± 1.3 0.380
Adipocytokines* n =  13 n =  46
• Leptin (pg/ml) 69.8 ± 26.6 292 ± 52 0.0163
• Total adiponectin (ng/ml) 8049 ± 1081 15,268 ± 1133 0.0017
• HMW adiponectin (ng/ml) 4409 ± 757 9356 ± 761 0.0014
Amino acids
• Alanine 153 ± 27.4 217 ± 16.2 0.0330
• Valine 100 ± 10.7 75.6 ± 6.3 0.0248
• Phenylalanine 79.6 ± 7.7 43.0 ± 4.5 0.0067




• IL-2 (pg/ml) 7.7 ± 2.7 3.6 ± 1.2 0.0158
• TNF-α (pg/ml) 43.0 ± 5.5 37.4 ± 9.5 0.0248
Other
• Glucose (mg/dl) 77.1 ± 7.9 85.9 ± 3.9 0.474
• Creatinine (mg/dl) 0.30 ± 0.04 0.27 ± 0.03 0.296
• Triglycerides (mg/dl) 177.6 ± 14.0 122.9 ± 12.2 0.0008
*Excludes patients on ARVs.
Adapted from [22].
Table 1. 
Relevant baseline metabolic profile of HIV-infected and HIV-negative patients. Bold values denote statistical 
significance at the p<0.05 level.
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patients [19]. In fact, HIV-infected patients have, in general, an enhanced activity of 
proinflammatory cytokines (TNF-α, IL-1, IL-6, and others), which can cause in chil-
dren among other side effects retarded growth and a loss in body weight. At the same 
time, such immune-compromised children will acquire opportunistic infections, 
which will decrease by themselves the intake of food, thus leading to the aggrava-
tion of the immunodeficiency state and the higher incidence of several overlapping 
infections, such as tuberculosis, oral and esophageal candidiasis, pneumonia, skin 
infections, and persistent diarrhea. All these complications will negatively affect the 
nutritional status. In addition, anemia, which is a possible consequence of malnutri-
tion, is also a complication of HIV infection that can cause growth retardation in 
children [2, 15, 20]. These children often require highly aggressive management pro-
tocols including intensive antimicrobial administrations and the provision of a well-
balanced nutritional, higher caloric diet [20, 21]. The cooccurrence of tuberculosis 
adds another complication related to the decrease in the sensitivity of tuberculin skin 
test (TST), which is used as an indicator for management. This issue is aggravated 
further in immune-compromised children from HIV and severe malnutrition; there 
is a block of the immune reaction, type IV hypersensitivity, needed for a reactive 
TST, consequently affecting the appropriate management protocol [20, 21].
In addition, it was documented that the energy needs increase in HIV-infected 
children compared to normal children by almost 10% in the early stage of the disease. 
However, such an increased demand will go up to 20–30% in symptomatic HIV with 
opportunistic infections and to 50–100% in case of severe malnutrition. These data 
are based on studies in HIV-infected adults or in non-HIV-infected children and, 
therefore, have a low level of evidence [2]. A major finding of these studies is that HIV-
infected children with SAM present with significant reductions in the adipocytokines, 
leptin, and adiponectin that are associated with mortality during inpatient hospital-
ization. In addition, HIV-infected and HIV-negative patients presented with similar 
degrees of wasting and edema, who achieved similar rates of growth and recovery [22]. 
Accordingly, as evidenced in Table 1, a baseline metabolic profile including amino acid 
levels was suggested for HIV-infected and HIV-negative patients [22].
5. Nutrition as an adjunct therapy
The introduction of therapeutic nutrition support and appropriate fluid 
rehydration has improved the rehabilitation process, shortened hospital stays of 
HIV-uninfected severely malnourished children, and addressed micronutrient and 
macronutrient deficiencies [19]. In the stabilization phase, F-75 is given as a therapeu-
tic food. It is a low-protein milk-based formula diet. It is followed gradually by F-100 
over a couple of days. The transitional phase until rehabilitation phase is reached. 
F-100 is a milk formula with higher protein and energy content than F75. However, 
the ready-to-use therapeutic food (RUTF) has replaced the F-100, especially in cases 
of severe acute malnutrition. In general, RUTF are pastes, no liquids, containing a 
combination of milk powder, electrolytes, and micronutrients. They provide the child 
with the same nutrients as F-100 plus iron [3, 4, 7]. As for rehydration, ReSoMal is 
commonly used. It contains approximately 45 mmol Na, 40 mmol K, and 3 mmol Mg 
per liter [19]. However, the metabolic and nutrient needs of HIV-infected children, in 
whom persistent anorexia is frequent, should be more clearly defined. In case of severe 
diarrhea often associated with high mortality rates, the provision of suitable feeding 
protocols is highly recommended. In brief, protocols for appropriate nutrition support 
therapy for severely malnourished infants below age 6 months are needed [23].
Although wasting can be treated in HIV-uninfected children with nutritional 
therapy alone, effective regimens for HIV-infected children need to be developed. 
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The use of high-energy therapeutic nutrition support (e.g., F100 or RUTF) is part 
of standard care that can start the soonest regardless of the ART starting date. 
However, high mortality (38%), within 4–6 weeks, remains an issue. Many children 
will gain weight with nutrition support alone. Sometimes, CD4 cell count could be 
used to monitor the nutritional needs and to identify those needing treatment [15]. 
However, other reports pointed out that CD4 cell counts do not seem to improve 
after the provision of nutritional therapy. In brief, community therapeutic care 
methods, strengthened by local production of ready-to-use therapeutic foods, 
require fewer staff to run programs and ensure compliance. It is also worth noting 
that the HIV epidemic has generated a new group of children requiring nutrition 
rehabilitation unit-based care [20].
The situation becomes more complicated when opportunistic infections enter 
the picture, necessitating the use of anti-infective medications in malnourished 
children. Such drugs have a wide range of toxicity, which worsen the nutritional 
status of the children [18, 21]. Such children require urgent stabilization of multiple 
physiological parameters including hypoglycemia, dehydration, and electrolyte 
imbalance. Nutritional support is generally tailored to each case with consideration 
given to the rate of weight gain [10, 21].
Although interventions with multiple nutritional regimens increase energy 
and protein intake, in such situations, they led to no improvement in the morbid-
ity and mortality rates compared to placebo. Observational studies have reported 
that the recovery from acute malnutrition and underweight using ready-to-use 
therapeutic food (RUTF) in populations of malnourished children, including some 
infected with HIV, was often complete with these products [2, 17, 19]. It was also 
noted that severe wasting makes the clinical assessment of dehydration difficult, 
so the presence of metabolic acidosis and lethargy are often the clinical indications 
available to prompt rehydration and nutritional interventions. Unfortunately, there 
are also currently inadequate data on the optimum regimen of supportive care (e.g., 
for shock) in the malnourished child who has adapted to a reduced body mass and 
organ system function. Appropriate dietary therapies are needed for this increasing 
population, as the standard F-75 and F-100 formulas are likely unsuitable [3, 21]; 
they might lead to the refeeding syndrome. Refeeding syndrome can be defined as 
the potentially fatal shifts in fluids and electrolytes that may occur in malnourished 
patients receiving artificial refeeding whether enterally or parenterally [19].
Besides, in Jesson and Leroy review, vitamin A was used as a primary therapy; it 
decreased pediatric mortality by 50% whatever the cause and improved short-term 
growth, in untreated HIV-infected children in Tanzania [2].
6. Antiretroviral therapy (ART) and nutrition
It is well documented that the availability of highly active antiviral therapy 
(HAART) for the past two decades or so has decreased remarkably the mortality 
and morbidity of the disease in both adults and children, thus transforming it 
into a chronic infections disease [9]. The prognosis of HIV-infected children has 
markedly improved in the HAART era, both in terms of morbidity and mortality as 
mentioned earlier, despite the fact the mortality rate in HIV-infected children is still 
considerably higher than the pediatric general population [9, 23].
In Tanzania, when ART became available, the recovery was improved, especially 
when ART was initiated in children at the same time as nutritional support than 
when it was initiated later [2].
In the literature, there seems to be conflicting recommendations about when and 
how to begin nutrition support with ART. Some studies have reported that if ART 
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is started when children have severe wasting due to malnutrition, they have higher 
rates of mortality compared to those with less clinical markers of malnutrition. 
However, studies were not conclusive about the time to start nutritional support 
[5, 15]. A recent retrospective study finding suggests that starting ART early in 
malnourished children results in higher rates of nutritional recovery and weight 
gain than if ART is delayed. In a study performed on a cohort of children in Africa, 
59% of Zambian children were initially underweight and almost three quarters 
(72%) had slowed down or stopped growth when ART was administered. In these 
children, prominent improvements in both weight and height were recorded when 
nutritional support started in the initial stage after diagnosis at the same time as 
ART. In fact, the best increase was observed among children who were most under-
weight. Therefore, these lifesaving medications should not be delayed, and child 
health systems should embrace this approach in a programmatic manner [5, 21].
On the other hand, ART in children has been reported to result in metabolic disor-
ders, which negatively affect the nutrition status, particularly, at the initiation and first 
few months of treatment. Such side effects include nausea, vomiting, dysregulated lipid 
metabolism [5, 11], low bond density, and increased fractures [11, 22]. Consequently, at 
the initiation of ART, the nutritional status must be evaluated, particularly that about 
half of the children taking such treatment will be underweight. Such a condition could 
lead to chronic malnutrition of about two-thirds of HIV-infected children in countries 
with limited resources with a higher two to three times risk of death.
Nutritional evaluation, monitoring, and support are strongly recommended, 
especially at the initiation period and the first 2 months. Such measures proved to 
decrease morbidity and mortality [2, 10]. Children severely immunodeficient at 
initiation of ART may have a better growth outcome than nonimmunodeficient 
children at initiation. Children treated with ART become less immunodeficient, 
and their nutritional status improves [2]. In general, protease inhibitors (PI)-based 
treatments result in decreasing viral load, less resistant mutation, and better 
growth compared to non-PI-based regimens. Many authors focusing on this issue 
have reported that the earlier the treatment was initiated in children, the better 
the nutritional response in weight and height was [2, 23]. Malnourished children 
treated with ART may develop a kwashiorkor-like syndrome of IRIS (immune 
reconstitution inflammatory syndrome) [21]. However, in children with severe 
malnutrition, there has been a concern that standard dosing of ART may be inap-
propriate. This concern is based on the malnourishment metabolic alterations 
that could lead to subtherapeutic or toxic drug levels that may contribute to viral 
resistance and/or safety issues [2, 5, 14].
Implementation challenges in starting and maintaining children on ART also 
persist and are found throughout the chain of care in sub-Saharan Africa, especially 
in rural areas [21].
7. Recommendations
In children, transmission of HIV through breastfeeding remains a problem. 
Efforts have moved in support of safer feeding by promoting exclusive breastfeed-
ing for 6 months coupled with concomitant antiretroviral prophylaxis delivered to 
breastfeeding mothers or the infant [1, 18]. However, nutritional management of 
HIV-infected children remains a challenge in view of all the studies reviewed.
HIV-positive women living in resource-poor environments must balance opposing 
risks. In 2010, the WHO revised its position by recommending exclusive breastfeed-
ing for the first 6 months of life followed by complementary foods and then accompa-
nied by postnatal infant or maternal antiretroviral prophylaxis (WHO). In contrast, 
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the American Academy of Pediatrics recommends that HIV-infected mothers not to 
breastfeed their infants, regardless of maternal disease status, viral load, or ART and 
the British HIV association concurs [1, 18].
The important issue is to meet all nutrient needs and provide the required 
energy requirements. However, according to the WHO, some considerations 
are needed for safely replacing food. Such considerations are based on the fact 
that untreated HIV-infected patients have an increased resting energy expen-
diture, decreased appetite, digestion of food, and absorption of nutrients. In 
brief, such patients often have a range of micronutrient deficiencies. However, 
there are no evidence-based guidelines on the appropriate types and amounts 
of micronutrient supplements for HIV-infected children. The WHO has previ-
ously endorsed the use of ready-to-use therapeutic foods to reduce mortality 
and undernutrition [18].
8. Conclusion
In the area of nutrition and HIV, children deserve special attention because 
of their additional needs to ensure growth and development and their depen-
dency on adults for adequate care. Nutritional advice and support should be 
a priority component of the continuum of care for HIV-infected women and 
children. Furthermore, case by case, the special nutritional needs of children 
should be determined in light of the guidelines and recommendations adopted 
by various professional health and medical associations. Wasting and under-
nutrition in HIV-infected children reflect a series of failures within the health 
system, the home, and the community and not just a biological process related 
to virus and host interactions. In brief, despite the great impact of recent phar-
macologic interventions, optimal nutrition continues to be essential therapy 
for HIV-infected children, and it has the potential to provide adjunct immune-
modulatory therapy, thus improving care and outcomes of children with  
HIV/AIDS.
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